Glucovance and interstitial lung disease Patient Reports February 12, 2012
Glucovance Side Effects Report #5069605-1
Glucovance side effect was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Glucovance Side Effects Report #4569022-4
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with GLUCOPHAGE, VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON. Patient was hospitalized. Patient recovered.
Glucovance Side Effects Report #4585370-6
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: alveolitis, alveolitis allergic, central venous pressure increased, cryptogenic organizing pneumonia, feeling cold, glycosylated haemoglobin increased, interstitial lung disease, lung infiltration. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Glucovance Side Effects Report #4596643-5
Glucovance side effect was reported by a Consumer or non-health professional from on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Glucovance Side Effects Report #4734868-6
Glucovance side effect was reported by a Consumer or non-health professional from FRANCE on Aug 17, 2004. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Glucovance. After drug was administered, patient experienced the following side effects: interstitial lung disease. Glucovance dosage: unknown. During the same period patient was treated with VOLTAREN, ZOCOR, CLORAZEPATE DIPOTASSIUM, FEMOSTON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Glucovance and interstitial lung disease 